<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27408">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02749916</url>
  </required_header>
  <id_info>
    <org_study_id>KC15EIMI0104</org_study_id>
    <nct_id>NCT02749916</nct_id>
  </id_info>
  <brief_title>Contrast Enhanced SWI for Carotid Plaque Imaging</brief_title>
  <official_title>Contrast Enhanced Susceptibility Weighted Imaging (SWI) for Characterization of Carotid Plaque</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hyun Seok Choi, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare image-based characteristics of carotid walls between symptomatic
      side and the opposite side. The design of this study is phase IV, prospective observational
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atherosclerosis of craniocervical arteries are one of most important causes of stroke.
      Carotid artery is the most frequent site of atherosclerosis. Recent research in carotid
      artery covers not only morphology of lumen but also direct visualization of carotid plaque
      or vessel wall. Vulnerable carotid plaques share pathologic features of intra-plaque
      inflammation and hemorrhage. There have been reports about post-contrast SWI in the field of
      vascular imaging. We hypothesized SWI is so sensitive to gadolinium based contrast agent and
      hemorrhage that contrast-enhanced SWI can visualize vulnerable carotid plaque. The purpose
      of this study is to investigate gadolinium-enhanced SWI in detection of vulnerable carotid
      plaque and compare it with MP-RAGE and DANTE T1-SPACE. This can be used to guide proper
      treatment for stroke.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Week</target_duration>
  <primary_outcome>
    <measure>Detection rate of findings of vulnerable carotid plaque</measure>
    <time_frame>within 3 days after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy in delinating geometry of carotid inner lumen and outer wall</measure>
    <time_frame>within 3 days after enrollment</time_frame>
    <description>Diameter of inner lumen and outer wall; Area of inner lumen and outer wall</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Carotid Plaque Imaging</condition>
  <arm_group>
    <arm_group_label>Patients with acute or recent (within 3months) stroke</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Methods of carotid wall imaging</intervention_name>
    <arm_group_label>Patients with acute or recent (within 3months) stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute or recent (within 3months) stroke or TIA (transient ischaemic attack)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute or recent (within 3months) stroke or TIA

          -  50-70% stenosis of internal carotid artery by NASCET criteria

          -  Written informed consent, prior to registration

        Exclusion Criteria:

          -  Hemorrhagic stroke

          -  Previous history of carotid endarterectomy (CEA), angioplasty, or stenting

          -  Contraindication for MR imaging

          -  Hypersensitivity to gadolinium based contrast media

          -  Pregnant or lactating women

          -  Patients under age of 19-year-old

          -  Renal condition : eGFR &lt; 60

          -  Patients unable and/or unwilling to comply with treatment or study instructions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hyun Seok Choi, M.D.</last_name>
    <phone>82-2-2258-1439</phone>
    <email>hschoi@catholic.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Chai Jung, MD</last_name>
      <email>dynamics79@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun Seok Choi, MD</last_name>
      <email>hschoi@catholic.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Jinhee Jang, MD</last_name>
      <email>znee@catholic.ac.kr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>April 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Hyun Seok Choi, M.D.</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>SWI</keyword>
  <keyword>MP-RAGE</keyword>
  <keyword>DANTE T1-SPACE</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
